Skip to main content
Lawrence Tiglao, MD, Obstetrics & Gynecology, Fremont, CA

LawrenceMatthewTiglaoMD

Obstetrics & Gynecology Fremont, CA

Hospitalist

OB Hospitalist Medical Director

Dr. Tiglao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Tiglao's full profile

Already have an account?

  • Office

    2500 Mowry Ave
    Suite 255
    Fremont, CA 94538
    Phone+1 503-309-3601
    Fax+1 510-745-6465

Education & Training

  • University of California Davis Health
    University of California Davis HealthResidency, Obstetrics and Gynecology, 2010 - 2014
  • Oregon Health and Science University School of Medicine
    Oregon Health and Science University School of MedicineClass of 2010
  • University of California at Los Angeles
    University of California at Los AngelesB.S., Anthropology, Cum Laude, 2003 - 2006

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2025
  • CO State Medical License
    CO State Medical License 2024 - 2025
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

  • Special Resident in Minimally Invasive Gynecology Award CDMCAAGL, 2014
  • Most Valuable Student Award UCLA Stroke Study Program, 2004
  • Participant San Francisco General Hospital PVP program, 2004
  • Join now to see all

Publications & Presentations

Abstracts/Posters

  • Tumor-specific targeting with novel LXY-30 peptide linked nanoparticles for paclitaxel delivery in ovarian cancer mouse xenograft model.
    Suby, N., Xiao K., Yi, Y., Tiglao, L.M., Lam, K., SGO Annual Meeting, 1/1/2013
  • Incidence of Venous Thrombo-Embolism After Robotic Assisted Total Laparoscopic Hysterectomy for Endometrial Cancer.
    Suby N, Tiglao L.M., Leiserowitz G., WAGO Annual Meeting, 1/1/2012

Lectures

  • "Risk of invasive adenocarcinoma of the cervix following treatment of adenocarcinoma in situ (AIS): Can cotesting identify a group for which subsequent hysterectomy is... 
    5/1/2013

Press Mentions

  • MarinHealth Receives Quality and Sustainability Award for Achieving Low Cesarean Birth Rate
    MarinHealth Receives Quality and Sustainability Award for Achieving Low Cesarean Birth RateJune 15th, 2022